Monday, August 25, 2014 7:11:38 PM
PFS -- progression free survival
OS -- overall survival
DFS -- disease free survival
TTP -- time to progression
ORR -- objective response rate
CR -- complete response
PR -- partial response
HE -- Hospital Exemption
AA -- accelerated approval
MA -- marketing approval
SOC -- standard of care
IRB -- Institutional Review Board
IND -- Investigational new drug
NDA -- new drug application
BLA -- biologics license application
SSR -- sample size re-estimation
BSSR -- blinded sample size re-estimation
DMC -- data monitoring committee
DSMB -- data and safety monitoring board (basically same as DMC)
FDA -- Food and Drug Administration
EMA -- European Medicines Agency
PEI -- Paul Ehrlich Institute (Germany's FDA equivalent)
MHRA -- Medicines and Healthcare Products Regulatory Agency (UK)
Stat sig -- statistical significance
tx -- treatment or treatment group
pl -- placebo or placebo group
L -- DCVax-L
Direct -- DCVax-Direct
PDUFA -- prescription drug user fee act
ICT-107 -- IMUC's lead candidate for GBM
QOL -- quality of life
GBM -- glioblastoma multiform, i.e. stage IV brain cancer
rGBM -- recurrent GBM
ND-GBM -- newly diagnosed GBM
AL -- adaptive licensing
Those are probably the ones you'll see 99% of the time here, but by no means exhaustive. Here's more:
http://tracs.unc.edu/docs/regulatory/commonly_used_abbreviations_and_terms_in_clinical_trials.pdf
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM